SVB and Chinese Biotech Ventures: Challenges and Opportunities
In this special episode of China of Tomorrow, Liqian Ren speaks with Adam Sun, IC member of Oceanpine Capital’s healthcare industry investment. Adam joins Liqian from Beijing during the height of the Silicon Valley Bank collapse to discuss related impacts, as well as the VC investment landscape in biotech including risks, challenges and a macro-outlook for seeking growth opportunities in China.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.